Robotic Donor Hysterectomy Results in Technical Success and Live Births After Uterus Transplantation: Subanalysis Within the Dallas Uterus Transplant Study (DUETS) Clinical Trial.


Journal

Clinical obstetrics and gynecology
ISSN: 1532-5520
Titre abrégé: Clin Obstet Gynecol
Pays: United States
ID NLM: 0070014

Informations de publication

Date de publication:
01 03 2022
Historique:
entrez: 19 1 2022
pubmed: 20 1 2022
medline: 7 5 2022
Statut: ppublish

Résumé

Minimally invasive procurement of uterine grafts for transplantation can decrease living donor recovery time. We examined recipient outcomes for grafts procured by robotic-assisted donor hysterectomies with transvaginal extraction in the Dallas UtErus Transplant Study (DUETS). All 5 grafts were successfully transplanted. Recipients had a median 4.5-hour surgical time, 0.25 L estimated blood loss, and 4-day hospital stay. Four recipients had grade III surgical complications and three had acute cellular rejection. At 18 months, graft viability was 100%, with an 80% live birth rate. This report demonstrates the feasibility and reproducible success of using uterus grafts from living donors who underwent robotic-assisted donor hysterectomy.

Identifiants

pubmed: 35045026
doi: 10.1097/GRF.0000000000000678
pii: 00003081-202203000-00009
doi:

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

59-67

Informations de copyright

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Références

Lavoué V, Vigneau C, Duros S, et al. Which donor for uterus transplants: brain-dead donor or living donor? A systematic review. Transplantation. 2017;101:267–273.
Matoba Y, Kisu I, Banno K, et al. Operative and clinical outcomes of minimally invasive living-donor surgery on uterus transplantation: a literature review. J Clin Med. 2021;10:349.
Wall AE, Johannesson L, Sok M, et al. Decision making and informed consent in uterus transplant recipients: a mixed-methods study of the Dallas Uterus Transplant Study (DUETS) participants. Am J Surg. 2021;222:819–824.
Wei L, Xue T, Tao KS, et al. Modified human uterus transplantation using ovarian veins for venous drainage: the first report of surgically successful robotic-assisted uterus procurement and follow-up for 12 months. Fertil Steril. 2017;108:346.e1–356.e1.
Tzvetanov I, Bejarano-Pineda L, Giulianotti PC, et al. State of the art of robotic surgery in organ transplantation. World J Surg. 2013;37:2791–2799.
Ayoubi JM, Carbonnel M, Pirtea P, et al. Laparotomy or minimal invasive surgery in uterus transplantation: a comparison. Fertil Steril. 2019;112:11–18.
Puntambekar S, Puntambekar S, Telang M, et al. Novel anastomotic technique for uterine transplant using utero-ovarian veins for venous drainage and internal iliac arteries for perfusion in two laparoscopically harvested uteri. J Minim Invasive Gynecol. 2019;26:628–635.
Puntambekar S, Telang M, Kulkarni P, et al. Laparoscopic-assisted uterus retrieval from live organ donors for uterine transplant: our experience of two patients. J Minim Invasive Gynecol. 2018;25:622–631.
Brännström M, Dahm-Kähler P, Ekberg J, et al. Outcome of recipient surgery and 6-month follow-up of the Swedish live donor robotic uterus transplantation trial. J Clin Med. 2020;9:2338.
Brännström M, Dahm-Kähler P, Kvarnström N, et al. Live birth after robotic-assisted live donor uterus transplantation. Acta Obstet Gynecol Scand. 2020;99:1222–1229.
Brännström M, Kvarnström N, Groth K, et al. Evolution of surgical steps in robotics-assisted donor surgery for uterus transplantation: results of the eight cases in the Swedish trial. Fertil Steril. 2020;114:1097–1107.
Falcone T, Richards EG. Balancing innovation and safety: robotic-assisted donor surgery in uterus transplantation. Fertil Steril. 2020;114:976–977.
Johannesson L, Koon EC, Bayer J, et al. Dallas UtErus Transplant Study: early outcomes and complications of robot-assisted hysterectomy for living uterus donors. Transplantation. 2021;105:225–230.
Carmona F, Rius M, Díaz-Feijoo B, et al. Uterine transplantation. First viable case in Southern Europe. Med Clin (Barc). 2021;156:297–300.
Huang Y, Ding X, Chen B, et al. Report of the first live birth after uterus transplantation in People’s Republic of China. Fertil Steril. 2020;114:1108–1115.
Testa G, McKenna GJ, Bayer J, et al. The evolution of transplantation from saving lives to fertility treatment: DUETS (Dallas UtErus Transplant Study). Ann Surg. 2020;272:411–417.
Johannesson L, Wallis K, Koon EC, et al. Living uterus donation and transplantation: experience of interest and screening in a single center in the United States. Am J Obstet Gynecol. 2018;218:331.e1–331.e7.
Johannesson L, Testa G, Flyckt R, et al. Guidelines for standardized nomenclature and reporting in uterus transplantation: an opinion from the United States Uterus Transplant Consortium. Am J Transplant. 2020;20:3319–3325.
Testa G, Koon EC, Johannesson L, et al. Living donor uterus transplantation: a single center’s observations and lessons learned from early setbacks to technical success. Am J Transplant. 2017;17:2901–2910.
Agarwal A, Johannesson L, Findeis SK, et al. Clinicopathologic analysis of uterine allografts including proposed scoring of ischemia-reperfusion injury and T cell-mediated rejection—Dallas UtErus Transplant Study: a pilot study. Transplantation. 2021. doi:10.1097/TP.0000000000003633
doi: 10.1097/TP.0000000000003633
Johannesson L, Wall A, Warren AM, et al. Decisions on second pregnancy after uterus transplantation and timing for removal of the uterus-DUETS (Dallas UtErus Transplant Study). BJOG. 2021;128:1610–1614.
Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187–196.
Jones BP, Saso S, Bracewell-Milnes T, et al. Human uterine transplantation: a review of outcomes from the first 45 cases. BJOG. 2019;126:1310–1319.
Johannesson L, Testa G, Putman JM, et al. Twelve live births after uterus transplantation in the Dallas UtErus Transplant Study. Obstet Gynecol. 2021;137:241–249.

Auteurs

Liza Johannesson (L)

Annette C. and Harold C. Simmons Transplant Institute.
Department of Obstetrics and Gynecology, Baylor University Medical Center.

Anji E Wall (AE)

Annette C. and Harold C. Simmons Transplant Institute.

Johanna Bayer (J)

Annette C. and Harold C. Simmons Transplant Institute.

Greg J McKenna (GJ)

Annette C. and Harold C. Simmons Transplant Institute.

Matthew Rosenzweig (M)

Annette C. and Harold C. Simmons Transplant Institute.

Briget DA Graca (B)

Baylor Scott and White Research Institute, Dallas, Texas.

Eric C Koon (EC)

Department of Obstetrics and Gynecology, Baylor University Medical Center.

Giuliano Testa (G)

Annette C. and Harold C. Simmons Transplant Institute.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH